Alzheimer’s dementia (AD) is increasingly being recognized as one of the most important
medical and social problems in older people in industrialized and non-industrialized nations. …

Disease-modifying treatment strategies for Alzheimer disease (AD) are still under extensive
research. Nowadays, only symptomatic treatments exist for this disease, all trying to …

Background Frontotemporal dementia is a heterogenous neurodegenerative disorder, with
about a third of cases being genetic. Most of this genetic component is accounted for by …

Background The novel coronavirus disease (COVID‐19) was first detected in Mainland China
in December 2019, and soon it spread throughout the world, with multiple physical and …

Physical as well as cognitive training interventions improve specific cognitive functions but
effects barely generalize on global cognition. Combined physical and cognitive training may …

INTRODUCTION Alzheimer’s disease (AD) is a fatal neurodegenerative disease in which
progressive brain degeneration compromises cognitive function. AD neurodegeneration is …

Purpose: The purpose of this study was to evaluate the macular and retinal nerve fiber layer
(RNFL) thickness, and the electrical activity of the macula in patients with Alzheimer's …

Background The SNCA gene encoding α‐synuclein (αSyn) is the first gene identified to cause
autosomal‐dominant Parkinsonʼs disease (PD). Objective We report the identification of …

Alzheimer’s disease (AD) is the most common neurodegenerative disorder with obscure
pathogenesis and no disease-modifying therapy to date. AD is multifactorial disease that …

Objectives: The Long Lasting Memories (LLM) program concerns a newly integrated platform
which combines cognitive exercises with physical activity within the context of advanced …